ARDELYX, INC. (ARDX)

Latest Insider Confidence Score

2026Q1

48.5
Bearish

Company insider confidence (by quarter)

2014Q4 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Barrett M James 10% Owner 9,169,210 May 30, 2018
New Enterprise Associates 12, Limited Partnership 10% Owner 8,086,401 Jun 12, 2020
Makhzoumi Mohamad — 6,164,372 Jul 17, 2018
Barris Peter J 10% Owner 5,629,734 Dec 16, 2014
Drant Ryan D 10% Owner 5,629,734 Dec 16, 2014

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 24, 2026 Feb 25, 2026 RAAB MICHAEL CEO Sell 41.3 -41,666 -2.19% ✓ $260.6K
Feb 20, 2026 Feb 23, 2026 MOTT DAVID M Director Buy 100.0 +333,333 11.22% ✗ $1.9M
Feb 20, 2026 Feb 23, 2026 Bishop John E Officer Sell 48.8 -3,179 -0.93% ✗ $18.6K
Feb 20, 2026 Feb 23, 2026 Reilly Joseph James Officer Sell 46.3 -4,991 -3.18% ✗ $29.2K
Feb 20, 2026 Feb 23, 2026 Williams Laura A Officer Sell 46.3 -8,176 -1.84% ✗ $47.8K
Feb 20, 2026 Feb 23, 2026 Hohenleitner Susan CFO Sell 48.8 -2,033 -0.87% ✗ $11.9K
Feb 20, 2026 Feb 23, 2026 Brady James Parker Chief Human Resources Officer Sell 48.8 -2,543 -0.96% ✗ $14.9K
Feb 20, 2026 Feb 23, 2026 Kelliher Mike Officer Sell 42.5 -9,595 -2.56% ✗ $56.1K
Feb 20, 2026 Feb 23, 2026 RAAB MICHAEL CEO Sell 40.0 -45,982 -2.38% ✗ $268.8K
Feb 20, 2026 Feb 23, 2026 Foster Eric Duane Chief Commercial Officer Sell 42.5 -10,439 -2.39% ✗ $61K
Jan 23, 2026 Jan 27, 2026 Reilly Joseph James Officer Neutral 90.0 +46,200 41.78% ✗ -
Jan 23, 2026 Jan 26, 2026 Kelliher Mike Officer Neutral 90.0 +103,080 38.01% ✗ -
Jan 23, 2026 Jan 26, 2026 Hohenleitner Susan CFO Neutral 90.0 +85,670 58.32% ✗ -
Jan 23, 2026 Jan 26, 2026 Foster Eric Duane Chief Commercial Officer Neutral 90.0 +137,945 46.22% ✗ -
Jan 23, 2026 Jan 26, 2026 RAAB MICHAEL CEO Neutral 90.0 +446,220 30.11% ✗ -
Jan 23, 2026 Jan 26, 2026 Brady James Parker Chief Human Resources Officer Neutral 90.0 +99,455 59.91% ✗ -
Jan 23, 2026 Jan 26, 2026 Williams Laura A Chief Patient Officer Neutral 90.0 +82,695 22.87% ✗ -
Jan 23, 2026 Jan 26, 2026 Bishop John E Officer Neutral 90.0 +124,330 57.03% ✗ -
Jan 8, 2026 Jan 9, 2026 Williams Laura A Chief Patient Officer Sell 20.0 -50,000 -12.15% ✗ $348.9K
Nov 21, 2025 Nov 25, 2025 GRAMMER ELIZABETH A Officer Sell 46.3 -5,995 -1.96% ✗ $33.2K
Nov 21, 2025 Nov 25, 2025 RAAB MICHAEL CEO Sell 40.0 -46,887 -3.07% ✗ $259.6K
Nov 21, 2025 Nov 25, 2025 Kelliher Mike Officer Sell 46.3 -5,560 -2.01% ✗ $30.8K
Nov 21, 2025 Nov 25, 2025 Williams Laura A Chief Patient Officer Sell 46.3 -6,426 -1.75% ✗ $35.6K
Nov 21, 2025 Nov 25, 2025 Foster Eric Duane Chief Commercial Officer Sell 46.3 -5,814 -1.93% ✗ $32.2K
Nov 21, 2025 Nov 25, 2025 Reilly Joseph James Officer Sell 42.5 -11,086 -9.24% ✗ $61.4K
Nov 7, 2025 Hohenleitner Susan CFO Neutral 52.5 - 0.00% ✗ -
Oct 17, 2025 Bishop John E Officer Neutral 52.5 - 0.00% ✗ -
Oct 17, 2025 Conner Edward R. Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Oct 17, 2025 Brady James Parker Chief Human Resources Officer Neutral 52.5 - 0.00% ✗ -
Aug 26, 2025 Aug 28, 2025 Williams Laura A Chief Patient Officer Sell 20.0 -80,000 -17.92% ✗ $489.7K
Aug 21, 2025 Aug 28, 2025 Kelliher Mike Chief Business Officer Sell 46.3 -5,417 -1.92% ✗ $32.1K
Aug 21, 2025 Aug 25, 2025 Williams Laura A Chief Patient Officer Sell 46.3 -6,261 -1.56% ✗ $37.1K
Aug 21, 2025 Aug 25, 2025 Renz Justin A CFO Sell 46.3 -7,037 -1.69% ✗ $41.7K
Aug 21, 2025 Aug 25, 2025 RAAB MICHAEL CEO Sell 40.0 -45,687 -2.90% ✗ $271K
Aug 21, 2025 Aug 25, 2025 GRAMMER ELIZABETH A Officer Sell 46.3 -5,841 -1.87% ✗ $34.6K
Aug 21, 2025 Aug 25, 2025 Foster Eric Duane Chief Commercial Officer Sell 42.5 -15,308 -4.83% ✗ $90.8K
Jun 18, 2025 Jun 23, 2025 Bazemore Robert B Director Neutral 90.0 +41,551 100.00% ✗ -
Jun 18, 2025 Jun 23, 2025 Rodgers Richard J Director Neutral 90.0 +63,019 17.98% ✗ -
Jun 18, 2025 Jun 23, 2025 Parsey Merdad Director Neutral 90.0 +15,235 36.23% ✗ -
Jun 18, 2025 Jun 23, 2025 MOTT DAVID M Director Neutral 82.5 +72,714 2.51% ✗ -
Jun 18, 2025 Jun 23, 2025 Cadoret-Manier Onaiza Director Neutral 90.0 +41,551 37.72% ✗ -
Jun 18, 2025 Jun 23, 2025 Bhanji Muna Director Neutral 90.0 +41,551 43.37% ✗ -
Jun 18, 2025 Jun 23, 2025 Bertrand William C JR Director Neutral 90.0 +60,941 26.52% ✗ -
Jun 16, 2025 Jun 18, 2025 MOTT DAVID M Director Buy 92.5 +200,000 7.42% ✗ $725.9K
Jun 9, 2025 Jun 11, 2025 MOTT DAVID M Director Buy 92.5 +200,000 8.01% ✗ $737.3K
May 20, 2025 May 22, 2025 Williams Laura A Chief Medical Officer Sell 46.3 -6,421 -1.57% ✗ $26.2K
May 20, 2025 May 22, 2025 Renz Justin A CFO Sell 46.3 -7,218 -1.71% ✗ $29.5K
May 20, 2025 May 22, 2025 RAAB MICHAEL CEO Sell 42.5 -46,817 -2.89% ✗ $191.1K
May 20, 2025 May 22, 2025 Kelliher Mike Officer Sell 42.5 -14,522 -4.89% ✗ $59.3K
May 20, 2025 May 22, 2025 GRAMMER ELIZABETH A Officer Sell 46.3 -5,992 -1.89% ✗ $24.5K
May 20, 2025 May 22, 2025 Foster Eric Duane Chief Commercial Officer Sell 48.8 -2,507 -0.79% ✗ $10.2K
May 15, 2025 May 19, 2025 MOTT DAVID M Director Buy 90.0 +100,000 4.17% ✗ $329.1K
Apr 28, 2025 May 14, 2025 Parsey Merdad Director Neutral 90.0 +42,056 100.00% ✗ -
May 13, 2025 Parsey Merdad Director Neutral 52.5 - 0.00% ✗ -
May 2, 2025 May 5, 2025 MOTT DAVID M Director Buy 100.0 +381,377 18.92% ✗ $1.6M
May 2, 2025 May 5, 2025 RAAB MICHAEL CEO Sell 41.3 -41,666 -2.51% ✓ $177.2K
Apr 4, 2025 Apr 8, 2025 RAAB MICHAEL CEO Sell 41.3 -41,666 -2.48% ✓ $191.2K
Mar 7, 2025 Mar 7, 2025 RAAB MICHAEL CEO Sell 41.3 -41,668 -2.45% ✓ $223.2K
Feb 25, 2025 Feb 27, 2025 Williams Laura A Chief Medical Officer Neutral 90.0 +105,200 34.63% ✗ -
Feb 25, 2025 Feb 27, 2025 Renz Justin A CFO Neutral 90.0 +136,680 47.80% ✗ -
Feb 25, 2025 Feb 27, 2025 RAAB MICHAEL CEO Neutral 90.0 +570,217 51.32% ✗ -
Feb 25, 2025 Feb 27, 2025 Kelliher Mike Officer Neutral 90.0 +136,680 85.43% ✗ -
Feb 25, 2025 Feb 27, 2025 GRAMMER ELIZABETH A Officer Neutral 90.0 +136,680 75.50% ✗ -
Feb 25, 2025 Feb 27, 2025 Foster Eric Duane Chief Commercial Officer Neutral 90.0 +136,680 75.93% ✗ -
Feb 24, 2025 Feb 26, 2025 MOTT DAVID M Director Buy 90.0 +77,729 4.01% ✗ $388.7K
Feb 20, 2025 Feb 21, 2025 Williams Laura A Chief Medical Officer Sell 46.3 -4,941 -1.60% ✗ $27.8K
Feb 20, 2025 Feb 21, 2025 Renz Justin A CFO Sell 46.3 -5,171 -1.78% ✗ $29.1K
Feb 20, 2025 Feb 21, 2025 RAAB MICHAEL CEO Sell 42.5 -22,964 -2.02% ✗ $129.1K
Feb 20, 2025 Feb 21, 2025 GRAMMER ELIZABETH A Officer Sell 46.3 -4,291 -2.32% ✗ $24.1K
Jan 31, 2025 Jan 31, 2025 RAAB MICHAEL CEO Sell 37.5 -41,666 -3.54% ✓ $223.4K
Jan 21, 2025 Jan 22, 2025 MOTT DAVID M Director Buy 97.5 +199,000 11.44% ✗ $992.7K
Jan 16, 2025 Jan 17, 2025 Rodgers Richard J Director Neutral 52.5 - 0.00% ✗ -
Jan 7, 2025 Jan 10, 2025 RAAB MICHAEL CEO Sell 37.5 -41,666 -3.48% ✓ $221.3K
Dec 26, 2024 Dec 27, 2024 MOTT DAVID M Director Neutral 52.5 - 0.00% ✗ -
Dec 19, 2024 Dec 23, 2024 MOTT DAVID M Director Buy 97.5 +213,300 14.96% ✗ $996.6K
Dec 10, 2024 Dec 12, 2024 RAAB MICHAEL CEO Sell 41.3 -25,000 -2.08% ✓ $131.6K
Nov 25, 2024 Nov 27, 2024 RAAB MICHAEL CEO Sell 41.3 -25,000 -2.08% ✓ $134.5K
Nov 20, 2024 Nov 22, 2024 Williams Laura A Chief Medical Officer Sell 46.3 -7,366 -2.33% ✗ $35.3K
Nov 20, 2024 Nov 22, 2024 Rosenbaum David P. Chief Development Officer Sell 46.3 -7,184 -1.35% ✗ $34.4K
Nov 20, 2024 Nov 22, 2024 Renz Justin A CFO Sell 46.3 -5,260 -1.77% ✗ $25.2K
Nov 20, 2024 Nov 22, 2024 RAAB MICHAEL CEO Sell 42.5 -31,980 -2.59% ✗ $153.3K
Nov 20, 2024 Nov 22, 2024 GRAMMER ELIZABETH A Officer Sell 46.3 -7,046 -3.66% ✗ $33.8K
Nov 20, 2024 Nov 22, 2024 Blanks Robert Officer Sell 46.3 -4,941 -1.55% ✗ $23.7K
Nov 19, 2024 Reilly Joseph James Officer Neutral 52.5 - 0.00% ✗ -
Nov 13, 2024 Nov 14, 2024 MOTT DAVID M Director Buy 97.5 +215,868 17.85% ✗ $996.6K
Nov 11, 2024 Nov 12, 2024 RAAB MICHAEL CEO Sell 53.8 -2,743 -0.22% ✓ $13.4K
Nov 6, 2024 Nov 8, 2024 Rosenbaum David P. Chief Development Officer Sell 22.5 -27,171 -4.85% ✗ $165.7K
Nov 4, 2024 Nov 6, 2024 Rosenbaum David P. Chief Development Officer Sell 22.5 -27,172 -4.85% ✗ $161.7K
Oct 28, 2024 Oct 31, 2024 RAAB MICHAEL CEO Sell 45.0 -25,000 -1.98% ✓ $147.7K
Oct 11, 2024 Oct 15, 2024 RAAB MICHAEL CEO Sell 51.3 -7,500 -0.60% ✓ $45.1K
Sep 27, 2024 Oct 1, 2024 Rosenbaum David P. Chief Development Officer Sell 26.3 -49,564 -8.51% ✓ $343K
Sep 26, 2024 Sep 27, 2024 RAAB MICHAEL CEO Sell 53.8 -3,000 -0.24% ✓ $18.2K
Sep 13, 2024 Sep 16, 2024 Rosenbaum David P. Chief Development Officer Sell 36.3 -5,312 -0.90% ✗ $33.3K
Sep 11, 2024 Sep 13, 2024 RAAB MICHAEL CEO Sell 41.3 -35,000 -2.73% ✓ $196.4K
Aug 27, 2024 Aug 28, 2024 RAAB MICHAEL CEO Sell 51.3 -7,500 -0.60% ✓ $46.6K
Aug 20, 2024 Aug 22, 2024 Williams Laura A Chief Medical Officer Sell 46.3 -7,412 -2.30% ✗ $43.4K
Aug 20, 2024 Aug 22, 2024 Rosenbaum David P. Chief Development Officer Sell 46.3 -7,219 -1.22% ✗ $42.3K
Aug 20, 2024 Aug 22, 2024 Renz Justin A CFO Sell 46.3 -5,289 -1.76% ✗ $31K
Aug 20, 2024 Aug 22, 2024 RAAB MICHAEL CEO Sell 42.5 -32,225 -2.51% ✗ $188.8K
Aug 20, 2024 Aug 22, 2024 GRAMMER ELIZABETH A Officer Sell 46.3 -7,089 -3.55% ✗ $41.5K